|
METTL5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.166800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.896000E-01 |
| Normal-vs-Stage2 |
4.403200E-01 |
| Normal-vs-Stage3 |
5.701000E-01 |
| Normal-vs-Stage4 |
7.679000E-01 |
| Stage1-vs-Stage2 |
9.019000E-01 |
| Stage1-vs-Stage3 |
6.842200E-01 |
| Stage1-vs-Stage4 |
5.717000E-01 |
| Stage2-vs-Stage3 |
7.152400E-01 |
| Stage2-vs-Stage4 |
6.014400E-01 |
| Stage3-vs-Stage4 |
8.223400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.228400E-01 |
| Normal-vs-AfricanAmerican |
6.498600E-01 |
| Normal-vs-Asian |
3.925700E-02 |
| Caucasian-vs-AfricanAmerican |
8.829000E-01 |
| Caucasian-vs-Asian |
5.165800E-02 |
| AfricanAmerican-vs-Asian |
2.426000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.587200E-01 |
| Normal-vs-Female |
3.650000E-01 |
| Male-vs-Female |
7.768600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.007800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.778600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.808000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.954000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.657800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.694000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.364200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.138000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.840600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.353400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.736200E-01 |
| Classical-VS-Follicular |
2.575900E-03 |
| Classical-VS-Other |
2.830000E-01 |
| Classical-VS-Normal |
8.394400E-01 |
| Tall-VS-Follicular |
4.670200E-02 |
| Tall-VS-Other |
3.703400E-01 |
| Tall-VS-Normal |
7.756000E-01 |
| Follicular-VS-Other |
8.191800E-01 |
| Follicular-VS-Normal |
6.904700E-03 |
| Other-VS-Normal |
2.159400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.413800E-01 |
| Normal-vs-N1 |
4.105800E-01 |
| N0-vs-N1 |
9.487400E-01 |
|
|
